-
公开(公告)号:US20200087737A1
公开(公告)日:2020-03-19
申请号:US16691480
申请日:2019-11-21
Applicant: MYRIAD GENETICS, INC.
Inventor: Victor Abkevich , Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/6886 , C12Q1/6827 , G16B20/00
Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号:US20200010913A1
公开(公告)日:2020-01-09
申请号:US16576643
申请日:2019-09-19
Applicant: MYRIAD GENETICS, INC.
Inventor: Victor Abkevich , Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/6886
Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
-
公开(公告)号:US20170130263A1
公开(公告)日:2017-05-11
申请号:US15412404
申请日:2017-01-23
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
CPC classification number: C12Q1/6827 , C12Q1/6858 , C12Q1/6874 , C12Q1/6883 , G16B30/00 , C12Q2535/122 , C12Q2537/143
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
-
公开(公告)号:US20170314081A1
公开(公告)日:2017-11-02
申请号:US15649274
申请日:2017-07-13
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Jerry Lanchbury , Susanne Wagner , Victor Abkevich
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/156 , G16H50/20
Abstract: Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided.
-
公开(公告)号:US09574229B2
公开(公告)日:2017-02-21
申请号:US15010721
申请日:2016-01-29
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
CPC classification number: C12Q1/6827 , C12Q1/6858 , C12Q1/6874 , C12Q1/6883 , G06F19/22 , C12Q2535/122 , C12Q2537/143
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
Abstract translation: 提供了使用核酸测序检测等位基因不平衡的方法和系统。
-
公开(公告)号:US20220243276A1
公开(公告)日:2022-08-04
申请号:US17575301
申请日:2022-01-13
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Jerry Lanchbury , Susanne Wagner , Victor Abkevich
IPC: C12Q1/6886 , G16H50/20
Abstract: Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided.
-
公开(公告)号:US20220205022A1
公开(公告)日:2022-06-30
申请号:US17545611
申请日:2021-12-08
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/6827 , G16B30/00 , C12Q1/6858 , C12Q1/6874 , C12Q1/6883
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
-
公开(公告)号:US20200239943A1
公开(公告)日:2020-07-30
申请号:US16815963
申请日:2020-03-11
Applicant: MYRIAD GENETICS, INC.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/6827 , C12Q1/6883 , C12Q1/6858 , C12Q1/6874 , G16B30/00
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
-
9.
公开(公告)号:US09388472B2
公开(公告)日:2016-07-12
申请号:US14307708
申请日:2014-06-18
Applicant: Myriad Genetics, Inc.
Inventor: Victor Abkevich , Alexander Gutin , Kirsten Timms , Jerry Lanchbury
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , A61K31/282 , A61K33/24 , C12Q2600/106 , C12Q2600/154 , C12Q2600/156 , C12Q2600/158
Abstract: This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a cancer cell) contains an LOH signature are provided. Materials and methods for identifying cells (e.g., cancer cells) having a deficiency in homology directed repair (HDR) as well as materials and methods for identifying cancer patients likely to respond to a particular cancer treatment regimen also are provided.
Abstract translation: 本文件提供了评估样品(例如癌细胞)中存在杂合性(LOH)特征丧失的方法和材料。 例如,提供了用于确定细胞(例如,癌细胞)是否包含LOH标记的方法和材料。 还提供了用于鉴别具有同源性定向修复(HDR)缺陷的细胞(例如癌细胞)的材料和方法以及用于鉴定可能对特定癌症治疗方案作出反应的癌症患者的材料和方法。
-
公开(公告)号:US20140162886A1
公开(公告)日:2014-06-12
申请号:US14109163
申请日:2013-12-17
Applicant: Myriad Genetics, Inc.
Inventor: Alexander Gutin , Kirsten Timms , Jerry Lanchbury
CPC classification number: C12Q1/6827 , C12Q1/6858 , C12Q1/6874 , C12Q1/6883 , G06F19/22 , C12Q2535/122 , C12Q2537/143
Abstract: Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
Abstract translation: 提供了使用核酸测序检测等位基因不平衡的方法和系统。
-
-
-
-
-
-
-
-
-